Scholars@Duke publication: Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy.

Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy.

Publication , Journal Article

Riesmeyer, JS; Reid, PR; Miller, DL

Published in: Am J Cardiol

February 15, 2003

Published version (DOI) Link to item

Duke Scholars

Author James Enlou Tcheng Medicine, Cardiology

Published In

Am J Cardiol

DOI

10.1016/s0002-9149(02)03291-5

ISSN

0002-9149

Publication Date

February 15, 2003

Volume

Issue

Start / End Page

514 / 515

Location

United States

Related Subject Headings

Treatment Outcome
Research Design
Platelet Glycoprotein GPIIb-IIIa Complex
Platelet Aggregation Inhibitors
Peptides
Humans
Eptifibatide
Diabetes Complications
Data Interpretation, Statistical
Coronary Disease

Citation

APA

Chicago

ICMJE

MLA

NLM

Riesmeyer, J. S., Reid, P. R., & Miller, D. L. (2003). Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy. Am J Cardiol, 91(4), 514–515. https://doi.org/10.1016/s0002-9149(02)03291-5

Riesmeyer, Jeffrey S., Philip R. Reid, and Debra L. Miller. “Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy.” Am J Cardiol 91, no. 4 (February 15, 2003): 514–15. https://doi.org/10.1016/s0002-9149(02)03291-5.

Riesmeyer JS, Reid PR, Miller DL. Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy. Am J Cardiol. 2003 Feb 15;91(4):514–5.

Riesmeyer, Jeffrey S., et al. “Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy.” Am J Cardiol, vol. 91, no. 4, Feb. 2003, pp. 514–15. Pubmed, doi:10.1016/s0002-9149(02)03291-5.

Riesmeyer JS, Reid PR, Miller DL. Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy. Am J Cardiol. 2003 Feb 15;91(4):514–515.

Published In

Am J Cardiol

DOI

10.1016/s0002-9149(02)03291-5

ISSN

0002-9149

Publication Date

February 15, 2003

Volume

Issue

Start / End Page

514 / 515

Location

United States

Related Subject Headings

Treatment Outcome
Research Design
Platelet Glycoprotein GPIIb-IIIa Complex
Platelet Aggregation Inhibitors
Peptides
Humans
Eptifibatide
Diabetes Complications
Data Interpretation, Statistical
Coronary Disease